Login | Register

Afinitor Approved In Europe For Advanced Breast Cancer

E.U. approval has been granted to Novartis drug Afinitor® (everolimus) after successful completion of the Phase III BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) trial...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *